Requirements for different pharmaceutical forms or dosages [Regulatives / Guidelines]

posted by Mauricio Sampaio  – Brazil, 2020-07-13 15:52 (1463 d 12:38 ago) – Posting: # 21683
Views: 1,538

Dear, what is the guideline from EMA that I would found the bioavailability requirements for different pharmaceutical forms or dosages?
For example, comparing tablet vs suspension (with same dosage), extende release vs immediate release, tablet 500 mg vs tablet 250 mg (with same drug).

Thank you for any help!

Complete thread:

UA Flag
Activity
 Admin contact
23,101 posts in 4,857 threads, 1,644 registered users;
81 visitors (0 registered, 81 guests [including 7 identified bots]).
Forum time: 04:30 CEST (Europe/Vienna)

One can show the following: given any rule, however “fundamental”
or “necessary” for science, there are always circumstances
when it is advisable not only to ignore the rule,
but to adopt its opposite.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5